Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease

In recent years, many new treatments for relapsed/refractory (R/R) multiple myeloma (MM) have improved patient prognosis, but the prognosis of patients with extramedullary MM is still particularly poor. Therefore, more efficacious therapies and novel strategies are urgently needed for these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Haobin, Liu, Meijing, Yuan, Ting, Zhang, Huan, Cui, Rui, Li, Jingyi, Yuan, Jijun, Wang, Xiaofang, Wang, Yafei, Deng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374046/
https://www.ncbi.nlm.nih.gov/pubmed/34421924
http://dx.doi.org/10.3389/fimmu.2021.720571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374046/
https://www.ncbi.nlm.nih.gov/pubmed/34421924
http://dx.doi.org/10.3389/fimmu.2021.720571

Ejemplares similares